CBPO News and Press, China Biologic Products Holdings Inc. From 03/04/21

The Chinese economy’s steady recovery and the impressive GDP growth expected there have whetted investors’ appetite for Chinese stocks. While current regulatory scrutiny of Chinese companies and tensions between Washington and Beijing have resulted in a retreat by stocks includi...

China Biologic Announces Shareholders' Approval of Merger Agreement PR Newswire BEIJING , March 1, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceut...

While China’s tech giants are facing strict regulatory supervision because of their alleged unfair competition, other Chinese stocks have been able to capitalize handsomely on the Chinese economy’s rapid recovery from the coronavirus pandemic. As the country’s economy con...

China Biologic Announces Extraordinary General Meeting of Shareholders PR Newswire BEIJING , Jan. 25, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmac...

Image source: The Motley Fool. China Biologic Products Inc (NASDAQ: CBPO) Q3 2020 Earnings Call Nov 26, 2020 , 7:30 p.m. ET Operator Continue reading For further details see: China Biologic Products Inc (CBPO) Q3 2020 Earnings Call Transc...

China Biologic Products Holdings, Inc. (CBPO) Q3 2020 Earnings Conference Call November 25, 2020 07:30 ET Company Participants Philip Lisio - Investor Relations Joseph Chow - President and Chief Executive Officer Ming Yin - Senior Vice President Conference Call Participants Jason Liu - Credit...

The following slide deck was published by China Biologic Products Holdings, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: China Biologic Products Holdings, Inc. 2020 Q3 - Results - Earnings Call Presentation

China Biologic Products (CBPO): Q3 Non-GAAP EPS of $1.40 beats by $0.12; GAAP EPS of $0.99.Revenue of $138.5M (+1.8% Y/Y)Press Release For further details see: China Biologic Products EPS beats by $0.12

China Biologic Reports Financial Results for the Third Quarter of 2020 PR Newswire BEIJING, Nov. 24, 2020 BEIJING , Nov. 24, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integra...

Merger activity increased last week with four new deals announced. The acquisition of HD Supply Holdings by The Home Depot. The acquisition of Foundation Building Materials by American Securities. For further details see: Merger Arbitrage Mondays - Home Depot B...